NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 180 filers reported holding NEKTAR THERAPEUTICS in Q2 2016. The put-call ratio across all filers is 0.82 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $187,000 | -15.8% | 10,892 | -1.9% | 0.00% | -100.0% |
| Q1 2021 | $222,000 | +12.7% | 11,107 | -4.2% | 0.00% | 0.0% |
| Q4 2020 | $197,000 | -17.2% | 11,589 | -19.1% | 0.00% | 0.0% |
| Q3 2020 | $238,000 | -27.2% | 14,331 | +1.4% | 0.00% | 0.0% |
| Q2 2020 | $327,000 | +26.3% | 14,140 | -2.7% | 0.00% | 0.0% |
| Q1 2020 | $259,000 | +4.9% | 14,537 | +27.1% | 0.00% | 0.0% |
| Q4 2019 | $247,000 | +0.8% | 11,434 | -15.0% | 0.00% | 0.0% |
| Q3 2019 | $245,000 | -52.3% | 13,453 | -6.9% | 0.00% | -66.7% |
| Q2 2019 | $514,000 | +6.9% | 14,453 | +0.9% | 0.00% | 0.0% |
| Q1 2019 | $481,000 | +4.1% | 14,322 | +1.8% | 0.00% | 0.0% |
| Q4 2018 | $462,000 | -56.0% | 14,070 | -18.4% | 0.00% | -40.0% |
| Q3 2018 | $1,051,000 | +37.7% | 17,234 | +10.3% | 0.01% | +25.0% |
| Q2 2018 | $763,000 | -45.1% | 15,622 | +19.3% | 0.00% | -55.6% |
| Q1 2018 | $1,391,000 | +10.4% | 13,093 | -37.9% | 0.01% | +12.5% |
| Q4 2017 | $1,260,000 | +103.2% | 21,091 | -18.5% | 0.01% | +100.0% |
| Q3 2017 | $620,000 | +51.6% | 25,864 | +23.6% | 0.00% | +33.3% |
| Q2 2017 | $409,000 | -7.5% | 20,926 | +11.1% | 0.00% | 0.0% |
| Q1 2017 | $442,000 | +187.0% | 18,840 | +74.2% | 0.00% | +200.0% |
| Q2 2016 | $154,000 | – | 10,814 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TIRSCHWELL & LOEWY INC | 588,908 | $7,138,000 | 1.23% |
| Granahan Investment Management | 3,693,956 | $44,771,000 | 1.21% |
| NEA Management Company, LLC | 1,825,600 | $22,126,000 | 1.09% |
| FIC CAPITAL INC | 150,868 | $1,829,000 | 0.75% |
| Rhenman & Partners Asset Management AB | 181,797 | $2,203,000 | 0.66% |
| SOPHROSYNE CAPITAL LLC | 60,200 | $728,000 | 0.64% |
| HARVEY CAPITAL MANAGEMENT INC | 130,400 | $1,580,000 | 0.63% |
| Artal Group S.A. | 1,300,000 | $15,756,000 | 0.57% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 564,418 | $6,840,000 | 0.47% |
| OppenheimerFunds, Inc. | 24,400,000 | $295,728,000 | 0.35% |